VITASPRING BIOMEDICAL CO., LTD. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VITASPRING BIOMEDICAL CO., LTD. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-10-31 was $41.22K, a 12.89% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-07-31 was $41.22K, a 12.89% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-04-30 was $41.22K, a 12.89% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2022-10-31 was $36.51K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2023-10-31 | $41.22K 10-Q · filed 2026-01-30 | |
| 2023-07-31 | $41.22K 10-Q · filed 2026-01-30 | |
| 2023-04-30 | $41.22K 10-Q · filed 2026-01-30 | |
| 2022-10-31 | $36.51K 10-Q · filed 2026-01-30 | |
| 2022-07-31 | $36.51K 10-Q · filed 2026-01-30 | |
| 2022-04-30 | $36.51K 10-Q · filed 2026-01-30 |